Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial

Johannes F.E. Mann, Katherine R. Tuttle, Vlado Perkovic et al.|Nature Medicine|2024

Cited by 152